Qiyang Cheng

Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma.

Haiyang Xie, Lin Zhou, Shusen Zheng, 2018, American journal of cancer research.

ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.

Haiyang Xie, Lin Zhou, Shusen Zheng, 2020, Cancer letters.

ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

Haiyang Xie, Lin Zhou, Shusen Zheng, 2020, Molecular Cancer.

LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.

Haiyang Xie, Lin Zhou, Shusen Zheng, 2019, American journal of cancer research.

High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma

Shusen Zheng, K. Liang, Z. Lv, 2020, Oncogene.

Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis

Jian Wu, Diyu Chen, Wenxuan Wu, 2021, World Journal of Surgical Oncology.

Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma

Shusen Zheng, Lele Zhang, Liang Zhang, 2017, Medicine.

NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma

Lin Zhou, Shusen Zheng, Guangyuan Song, 2020, International journal of biological sciences.